![The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017 | Scientific Reports The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017 | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-70840-2/MediaObjects/41598_2020_70840_Fig6_HTML.png)
The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017 | Scientific Reports
![Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries | Scientific Reports Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-017-15922-4/MediaObjects/41598_2017_15922_Fig1_HTML.jpg)
Incidence and mortality of kidney cancer: temporal patterns and global trends in 39 countries | Scientific Reports
![The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017 | Scientific Reports The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017 | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-70840-2/MediaObjects/41598_2020_70840_Fig1_HTML.png)
The burden of kidney cancer and its attributable risk factors in 195 countries and territories, 1990–2017 | Scientific Reports
![Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories - The Lancet Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories - The Lancet](https://www.thelancet.com/cms/attachment/6a79540e-3d82-4bb2-a56b-aeba7fb90a90/gr1a.jpg)
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories - The Lancet
![Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/684b750a-03b5-4494-b310-768504324d01/gr1.jpg)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Technologies | Free Full-Text | Systematic Predictive Analysis of Personalized Life Expectancy Using Smart Devices Technologies | Free Full-Text | Systematic Predictive Analysis of Personalized Life Expectancy Using Smart Devices](https://www.mdpi.com/technologies/technologies-06-00074/article_deploy/html/images/technologies-06-00074-g005.png)
Technologies | Free Full-Text | Systematic Predictive Analysis of Personalized Life Expectancy Using Smart Devices
![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/3-Table1-1.png)
PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar
![PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/503346139e7d62281fc955036b1fe2a70e2b4ab6/5-Table3-1.png)
PDF] Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database | Semantic Scholar
![PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database](https://i1.rgstatic.net/publication/341002310_Development_of_the_clinical_calculator_for_mortality_of_patients_with_metastatic_clear_cell_type_renal_cell_carcinoma_An_analysis_of_patients_from_Korean_Renal_Cancer_Study_Group_database/links/5ea9743b45851592d6a8a5df/largepreview.png)
PDF) Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database
![Development and validation of a life expectancy calculator for US patients with prostate cancer - Chase - 2022 - BJU International - Wiley Online Library Development and validation of a life expectancy calculator for US patients with prostate cancer - Chase - 2022 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/5dddb1f4-f97a-4dd9-af15-67b45bc14879/bju15740-fig-0002-m.jpg)
Development and validation of a life expectancy calculator for US patients with prostate cancer - Chase - 2022 - BJU International - Wiley Online Library
![Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity - ScienceDirect Outcomes based on age in patients with metastatic renal cell carcinoma treated with first line targeted therapy or checkpoint immunotherapy: Older patients more prone to toxicity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1879406820305300-gr1.jpg)